6254 Participants Needed

Blood Pressure Management During Surgery for High Blood Pressure

Recruiting at 17 trial locations
RJ
FR
VL
DS
Overseen ByDaniel Sessler, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: The Cleveland Clinic
Must be taking: Antihypertensives
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine if tightly managing blood pressure during major surgeries can reduce serious complications such as heart problems, stroke, infections, or death within 30 days post-operation. Participants will receive either tight blood pressure management with specific medications (vasopressors) or usual care to assess which approach is more effective. Ideal candidates are over 45 years old, scheduled for major surgeries, and have conditions like diabetes requiring medication or a history of heart disease.

As an unphased trial, this study provides participants the chance to contribute to important research that could enhance surgical outcomes for many patients.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but it does require that you are already taking at least one medication for high blood pressure. It's best to discuss this with the trial team or your doctor.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that carefully controlling blood pressure during surgery is safe. Studies have found that this approach stabilizes blood pressure and reduces the risk of it dropping too low during the operation, making significant drops less likely.

Regarding medications used to maintain blood pressure, norepinephrine and phenylephrine are generally well-tolerated, according to research. These drugs help keep blood pressure steady during surgery. Studies have found that they do not cause serious kidney problems and are safe for use during operations.

Overall, both careful blood pressure management and the use of these medications have demonstrated promising safety results in previous studies.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores different strategies for managing blood pressure during surgery in patients with hypertension. The "tight blood pressure management" approach is unique as it specifically avoids the use of certain medications like ACE inhibitors and ARBs on the morning of surgery, and instead relies on norepinephrine or phenylephrine to maintain a higher intraoperative blood pressure. This contrasts with the "routine blood pressure management" that allows the use of standard medications as needed. By testing these approaches, researchers hope to find out if tightly controlling blood pressure with specific infusions offers better outcomes for surgical patients compared to usual care.

What evidence suggests that this trial's treatments could be effective for managing blood pressure during surgery?

Research has shown that carefully controlling blood pressure during surgery helps maintain a healthy level, reducing the risk of low blood pressure linked to heart or kidney issues. This trial will compare two approaches: tight blood pressure management and routine blood pressure management. In the tight blood pressure management arm, medications such as norepinephrine and phenylephrine maintain stable blood pressure during surgery. Studies have found that this careful approach may lower the chances of serious complications after surgery. In short, closely managing blood pressure during surgery could lead to fewer complications and a smoother recovery.16789

Who Is on the Research Team?

DI

Daniel I Sessler, MD

Principal Investigator

The University of Texas Health Science Center, Houston

Are You a Good Fit for This Trial?

The GUARDIAN Trial is for adults over 45 with high blood pressure who are taking medication for it and scheduled for major noncardiac surgery lasting at least 2 hours. They must be hospitalized overnight, have a certain level of systemic disease, direct blood pressure monitoring during surgery, and one additional risk factor like heart disease or diabetes. Exclusions include those needing organ transplants or specific surgeries, contraindications to the study drugs, or cognitive impairments.

Inclusion Criteria

I expect to stay in the hospital overnight or longer.
I am scheduled for a major surgery that is not heart-related and will last at least 2 hours.
I have a serious health condition that affects my daily life.
See 6 more

Exclusion Criteria

I need medicine through an IV to help control my blood pressure before surgery.
I am scheduled for brain surgery.
You have been diagnosed with dementia in the past.
See 9 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either tight or routine intraoperative blood pressure management during surgery

During surgery

Postoperative Monitoring

Participants are monitored for major perfusion-related complications and other outcomes

30 days

Follow-up

Participants are monitored for cognition and major adverse cardiac events

1 year

What Are the Treatments Tested in This Trial?

Interventions

  • Routine pressure management
  • Tight pressure management
  • Vasopressor
Trial Overview This trial tests two ways to manage blood pressure during major surgery: 'tight' management aims to keep intraoperative mean arterial pressure (MAP) ≥85 mmHg using norepinephrine or phenylephrine infusions; 'routine' management follows standard care without this strict MAP target.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: Tight blood pressure managementExperimental Treatment1 Intervention
Group II: Routine blood pressure managementExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

The Cleveland Clinic

Lead Sponsor

Trials
1,072
Recruited
1,377,000+

The University of Texas Health Science Center, Houston

Lead Sponsor

Trials
974
Recruited
361,000+

Published Research Related to This Trial

Hypertension is a common issue in surgical patients, often caused by systemic vasoconstriction, which can negatively impact surgical outcomes, making preoperative evaluation crucial.
Effective preoperative treatments for hypertension include oral beta-blockers and alpha2-adrenergic antagonists, while fast-acting agents like sodium nitroprusside and esmolol are used during and after surgery to manage hypertensive emergencies.
Strategies for managing perioperative hypertension.Goldberg, ME., Weaver, FA.[2008]
Continue antihypertensive medications up to the morning of surgery to maintain blood pressure control, ensuring the dose is taken with a small sip of water.
Aim to adjust antihypertensive therapy to achieve a blood pressure of less than 160/90 mm Hg for at least two weeks before surgery to reduce surgical risks.
Perioperative hypertension. The primary care physician's role.Thompson, D., Ampel, L.[2019]
In a study of 27 hypertensive patients undergoing anesthesia, the type of antihypertensive medication (clonidine, methyldopa, or reserpine) did not significantly affect blood pressure or heart rate changes during surgery.
Hypokalemia was identified as the most common postoperative complication across all groups, indicating a need for monitoring potassium levels in hypertensive patients undergoing anesthesia.
Circulatory changes during and after surgical anesthesia in hypertensive patients treated with clonidine, methyldopa and reserpine.Ryhänen, P., Hanhela, R., Jouppila, R., et al.[2013]

Citations

Tight perioperative blood pressure management to reduce ...Tight BP management markedly increased intraoperative MAP and reduced the amount of hypotension. In contrast, delaying chronic antihypertensive medications had ...
PeriOperative Quality Initiative (POQI) international ...This article presents updated consensus statements and recommendations on perioperative arterial pressure management developed during the 11th POQI ...
2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...An increasing number of individual studies and meta-analyses of observational data have reported a gradient of higher CVD risk from normal BP, ...
Study Details | NCT05416944 | Perioperative Personalized ...Rates of major complications and mortality in the first weeks after surgery remain very high: postoperative mortality is still around 2% in central Europe ...
5.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/40962376/
Intensive vs Conventional Intraoperative Blood Pressure ...Objectives: The purpose of this study was to determine whether intensive intraoperative blood pressure management reduces the incidence of a ...
Intensive vs Conventional Intraoperative Blood Pressure ...Patients assigned to intensive intraoperative blood pressure management experienced a lower burden of hypotension exposure, as assessed by ...
Intraoperative targeted blood pressure management and...With regard to safety outcomes, the patients assigned to targeted blood pressure management developed less severe intraoperative hypotension ...
PeriOperative Quality Initiative (POQI) international ...This article presents updated consensus statements and recommendations on perioperative arterial pressure management developed during the 11th POQI ...
Tight perioperative blood pressure management to reduce ...Conclusions Tight BP management markedly increased intraoperative MAP and reduced the amount of hypotension. In contrast, delaying chronic.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security